BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20410435)

  • 1. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis.
    Rajamani U; Essop MF
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C139-47. PubMed ID: 20410435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insulin resistance.
    Rajamani U; Joseph D; Roux S; Essop MF
    Acta Physiol (Oxf); 2011 Jun; 202(2):151-7. PubMed ID: 21385329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detrimental effects of acute hyperglycemia on myocardial glucose uptake.
    Joseph D; Kimar C; Symington B; Milne R; Essop MF
    Life Sci; 2014 Jun; 105(1-2):31-42. PubMed ID: 24747137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
    Marsh SA; Dell'Italia LJ; Chatham JC
    Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hexosamine biosynthetic pathway induces gene promoter activity of acetyl-CoA carboxylase beta.
    Imbriolo J; Mapanga RF; Essop MF
    Biochem Biophys Res Commun; 2014 Sep; 452(3):734-9. PubMed ID: 25195817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway.
    Chaveroux C; Sarcinelli C; Barbet V; Belfeki S; Barthelaix A; Ferraro-Peyret C; Lebecque S; Renno T; Bruhat A; Fafournoux P; Manié SN
    Sci Rep; 2016 Jun; 6():27278. PubMed ID: 27255611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
    Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
    Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol Through Upregulating Caveolin-3 Attenuates Post-Hypoxic Mitochondrial Damage and Cell Death in H9C2 Cardiomyocytes During Hyperglycemia.
    Deng F; Wang S; Zhang L; Xie X; Cai S; Li H; Xie GL; Miao HL; Yang C; Liu X; Xia Z
    Cell Physiol Biochem; 2017; 44(1):279-292. PubMed ID: 29130958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
    Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
    Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects.
    Rajapakse AG; Ming XF; Carvas JM; Yang Z
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H815-22. PubMed ID: 19136606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myricitrin Attenuates High Glucose-Induced Apoptosis through Activating Akt-Nrf2 Signaling in H9c2 Cardiomyocytes.
    Zhang B; Chen Y; Shen Q; Liu G; Ye J; Sun G; Sun X
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triterpene, methyl-3β-hydroxylanosta-9,24-dien-21-oate (RA3), attenuates high glucose-induced oxidative damage and apoptosis by improving energy metabolism.
    Sangweni NF; Mosa RA; Dludla PV; Kappo AP; Opoku AR; Muller CJF; Johnson R
    Phytomedicine; 2021 May; 85():153546. PubMed ID: 33799221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation.
    Jones DR; Keune WJ; Anderson KE; Stephens LR; Hawkins PT; Divecha N
    FEBS J; 2014 Aug; 281(16):3591-608. PubMed ID: 24938479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.
    Li SY; Sigmon VK; Babcock SA; Ren J
    Life Sci; 2007 Feb; 80(11):1051-6. PubMed ID: 17174344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
    Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.
    Mapanga RF; Rajamani U; Dlamini N; Zungu-Edmondson M; Kelly-Laubscher R; Shafiullah M; Wahab A; Hasan MY; Fahim MA; Rondeau P; Bourdon E; Essop MF
    PLoS One; 2012; 7(10):e47322. PubMed ID: 23091615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.